7 major pharma companies sign up to Parkinson's initiative
Seven of the world’s largest pharmaceutical companies have signed up to a ground-breaking new initiative to improve clinical trials for Parkinson's.
Enzo Cilenti launches Pedal for Parkinson's 2016
Registration opens today for our Pedal for Parkinson's events in Stratford-upon-Avon, Harrogate, Stirling and the Isle of Wight. Sign up to raise vital funds for Parkinson's UK!
New stem cell study helps explain spread of Parkinson's
Our scientists at the Parkinson's UK-funded Oxford Parkinson's Disease Centre have discovered new clues as to how Parkinson's spreads from cell to cell.
Parkinson's UK condemns disability benefits failures
We tell an influential committee of MPs that the quality of disability benefit assessments for people with Parkinson's requires significant improvements.
What should we be campaigning for?
We want to make sure we continue to campaign on the issues that are important to people affected by Parkinson's. So we're asking - what matters most to you?
Peers vote to ditch disability cuts
Parkinson's UK explains the impact of the House of Lords vote on Wednesday night, where Members voted to scrap Government plans to cut disability benefits for people with Parkinson's too unwell to work.
Are occupational therapy and physiotherapy effective in Parkinson's?
We believe that occupational therapy and physiotherapy can help to improve Parkinson's symptoms, despite new research this week that suggests otherwise.
People with Parkinson's speak out over benefits cuts
Parkinson's UK supporters have called on MPs to vote against plans to cut benefits for people too ill to work.
Common dementia drug could improve Parkinson's symptoms
Researchers at the University of Bristol have discovered that a common dementia drug, rivastigmine, could reduce falls in people with Parkinson's.
Picturing Parkinson's - a scientific art form
Today we announce the top images in our 2015 Picturing Parkinson's competition, celebrating the beauty and art in the research we fund.